An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine
<p>Objective: Despite the availability of vast group of drugs, treatment of depression still remains unsatisfactory. Serious adverse effects of anti-depressants lead to early withdrawal from treatment. One more important concern is the therapeutic lag of nearly 3-4 weeks. Therefore, newer targ...
Furkejuvvon:
Váldodahkkit: | Salim Sheikh (Dahkki), Pankaj Sonone (Dahkki), Chakar Dhar Tripathi (Dahkki), Veena Verma (Dahkki), Bushra Ahmed Karim (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
Annals of Psychiatry and Treatment - Peertechz Publications,
2020-12-15.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Ketamine; A better anti-depressant? An animal study evaluating the efficacy of citalopram, ketamine and their combination in animal models of depression
Dahkki: Salim Sheikh, et al.
Almmustuhtton: (2021) -
Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?
Dahkki: Salim Sheikh, et al.
Almmustuhtton: (2021) -
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Dahkki: J Gordon Millichap
Almmustuhtton: (2013) -
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
Dahkki: Te-Yu Hung, et al.
Almmustuhtton: (2011) -
N-Methyl-D-Aspartate Receptor Antibodies in Herpes Simplex Encephalitis
Dahkki: J Gordon Millichap
Almmustuhtton: (2013)